Plus Therapeutics, Inc. is an innovative clinical-stage pharmaceutical company based in Austin, Texas, specializing in the development of advanced cancer therapies and treatments for serious diseases. The company is at the forefront of creating proprietary drug delivery technologies designed to enhance therapeutic efficacy in oncology. With a strong pipeline of promising drug candidates, Plus Therapeutics is strategically positioned to deliver novel therapeutic options that address substantial unmet medical needs in the healthcare sector, aiming to improve patient outcomes and advance the standard of care in oncology.